Table 2.
Demographic characteristics of patients admitted for percutaneous coronary intervention in selected studies
| Hess et al. | Nakatsuma et al. | Landes et al. (*) | ||||
|---|---|---|---|---|---|---|
| Characteristics, n (%) | Cancer n = 496 |
No cancer n = 14,512 |
Cancer n = 1109 |
No cancer n = 11,071 |
Cancer n = 969 |
No cancer n = 969 |
| Age (years) | 68 (61.8) | 62 (53.7) | 73.2 ± 8.5 | 67.8 ± 11.1 | 76.6 ± 10.1 | 76.9 ± 9.2 |
| Men | 354 (71.4) | 9586 (66.1) | 825 (74.4) | 7976 (72) | 700 (72.2) | 700 (72.2) |
| Systemic hypertension | 334 (67.3) | 9478 (65.3) | 904 (81.5) | 9100 (82.2) | 843 (87) | 843 (87) |
| Diabetes mellitus | 129 (26) | 4013 (27.7) | 440 (39.7) | 4154 (37.5) | 318 (45.7) | 318 (45.7) |
| Hyperlipidemia | n/a | n/a | n/a | n/a | ||
| Active smoker | 238 (48) | 7712 (53.1) | 230 (20.7) | 3648 (33) | 230 (23.7) | 204 (21.1) |
| History of | ||||||
| Myocardial infarction | 246 (49.6) | 7414 (51.1) | 119 (10.7) | 1141 (10.3) | n/a | n/a |
| PCI | n/a | n/a | n/a | n/a | n/a | n/a |
| CABG | n/a | n/a | n/a | n/a | 185 (19.1) | 196 (20.2) |
| Stroke | 66 (13.3) | 1196 (8.2) | 142 (12.8) | 1149 (10.4) | 87 (9) | 63 (6.5) |
| Anemia | n/a | n/a | 228 (20.6) | 1165 (10.5) | n/a | n/a |
| Presentation | ||||||
| ACS | 329 (66.6) | 10,481 (72.4) | 317 (28.6) | 2992 (27) | 592 (61.1) | 527 (54.4) |
| Number of diseased vessels | ||||||
| 1 vessel | 255 (55.8) | 8839 (65.4) | n/a | n/a | 163 (16.9) | 175 (18.1) |
| 2 vessels | 131 (28.7) | 3095 (22.9) | n/a | n/a | 320 (33) | 310 (32) |
| 3 vessels | 71 (15.5) | 1574 (11.7) | n/a | n/a | 485 (50.1) | 369 (40.9) |
| Procedure | ||||||
| Drug-eluting stent | 164 (54.5) | 4209 (62.1) | 570 (51.4) | 6218 (56.2) | 392 (40.5) | 465 (48) |
| Bare metal stent | n/a | n/a | n/a | n/a | 529 (54.6) | 464 (47.9) |
| Treatment at discharge | ||||||
| Beta-blockers | 447 (90.1) | 13,077 (90.1) | 294 (27) | 3410 (31) | n/a | n/a |
| ACE/ARBs | 418 (84.3) | 10,992 (75.7) | 571 (51) | 6573 (59) | n/a | n/a |
| Statins | n/a | n/a | 487 (44) | 5816 (53) | n/a | n/a |
| Aspirin | 489 (98.6) | 14,355 (98.9) | 1092 (98) | 10,936 (99) | n/a | n/a |
| P2Y12 Inhibitors | 437 (88.1) | 11,023 (76) | 136 (13) | 1018 (9.3) | n/a | n/a |
ACE Angiotensin-Converting Enzyme; ACS Acute Coronary Syndrome; ARBs Angiotensin Receptor Blockers; CABG Coronary Artery Bypass Grafting; PCI Percutaneous Coronary Intervention
(*) data of the matched patients